dc.contributor.author | Haerter, Georg et al. | |
dc.date.accessioned | 2020-05-26T21:13:37Z | |
dc.date.available | 2020-05-26T21:13:37Z | |
dc.date.issued | 2020-05-01 | |
dc.identifier.uri | https://doi.org/10.1101/2020.04.28.20073767 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12663/1606 | |
dc.description.abstract | Data on people living with human immunodeficiency virus (PLWH) in the current SARS-CoV-2 pandemic is still scarce. This case series of 33 PLWH patients with COVID-19 reveals symptoms and outcome in this special population. Three out of 32 patients with documented outcome died (9%). However, 91% of the patients recovered and 76% have been classified as mild cases, indicating that there is no excess morbidity and mortality among PLWH with symptomatic COVID-19. All patients were on antiretroviral treatment, of them 22 on tenofovir-containing regimen, and 4 on the protease inhibitor darunavir. | en_US |
dc.language | English | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Coronavirus | en_US |
dc.subject | Infectious Diseases | en_US |
dc.subject | HIV | en_US |
dc.subject | SARS-CoV | en_US |
dc.subject | Betacoronavirus | en_US |
dc.subject | SARS Virus | en_US |
dc.subject | Anti-Retroviral Agents | en_US |
dc.title | COVID-19 in people living with human immunodeficiency virus: A case series of 33 patients | en_US |
eihealth.country | Global (WHO/OMS) | en_US |
eihealth.category | Clinical characterization and management | en_US |
eihealth.type | Published Article | en_US |
eihealth.maincategory | Save Lives / Salvar Vidas | en_US |
dc.relation.ispartofjournal | medRxiv | en_US |